Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non–small-cell lung cancer previously treated with platinum …

FV Fossella, R DeVore, RN Kerr, J Crawford… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To confirm the promising phase II results of docetaxel monotherapy, this phase
III trial was conducted of chemotherapy for patients with advanced non–small-cell lung …
被引用次数：1744 相关文章

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum …

FV Fossella, R DeVore, RN Kerr, J Crawford… - Journal of Clinical …, 2000 - cir.nii.ac.jp
抄録< jats: p> PURPOSE: To confirm the promising phase II results of docetaxel
monotherapy, this phase III trial was conducted of chemotherapy for patients with advanced …

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum …

FV Fossella, R DeVore, RN Kerr… - Journal of …, 2000 - mdanderson.elsevierpure.com
Purpose: To confirm the promising phase II results of docetaxel monotherapy, this phase III
trial was conducted of chemotherapy for patients with advanced non-small-cell lung cancer …

[引用][C] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum …

FV FOSSELLA, R DEVORE… - Journal of clinical …, 2000 - pascal-francis.inist.fr
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with
advanced non-small-cell lung cancer previously treated with platinum-containing …

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum …

FV Fossella, R DeVore, RN Kerr… - Journal of clinical …, 2000 - pubmed.ncbi.nlm.nih.gov
Purpose To confirm the promising phase II results of docetaxel monotherapy, this phase III
trial was conducted of chemotherapy for patients with advanced non-small-cell lung cancer …
[PDF] psu.edu

[PDF][PDF] Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With …

FV Fossella, R DeVore, RN Kerr, J Crawford… - Journal of Clinical …, 2000 - Citeseer
Purpose: To confirm the promising phase II results of docetaxel monotherapy, this phase III
trial was conducted of chemotherapy for patients with advanced non–small-cell lung cancer …

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum …

FV Fossella, R DeVore, RN Kerr… - Journal of Clinical …, 2000 - europepmc.org
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with
advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy …

[引用][C] Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With …

FV Fossella, R DeVore, RN Kerr… - Journal of …, 2000 - baptisthealth.elsevierpure.com
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With
Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing …

[引用][C] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with …

F FV - J Clin Oncol, 2000 - cir.nii.ac.jp
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with
advanced non-small-cell lung cancer previously treated with platinumcontaining chemotherapy …

[引用][C] Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum …

FV FOSSELLA, R DEVORE… - Journal of …, 2000 - American Society of Clinical …